Auris Medical Holding AG (EARS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
22 Pages - GLDATA62494
$250.00

Summary

Auris Medical Holding AG (Auris Medical) is a pharmaceutical company that develops pharmaceutical therapies to protect hearing and to silence tinnitus. The company's product pipeline comprise of AM-101, AM-111, AM-102 and AM-123. It operates two projects, AM-101 for the treatment of tinnitus, and AM-111 for the treatment of acute sensorineural hearing loss. The company also offers treatment for inner ear disorders due to ageing, acoustic overstimulation by excessive noise or exposure to ototoxic drugs and substances. Auris Medical is headquartered in Zug, Switzerland.

Auris Medical Holding AG (EARS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Auris Medical Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Auris Medical Holding AG, Medical Devices Deals, 2011 to YTD 2017 9
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Auris Medical Raises US$51 Million In Series C Financing 11
Partnerships 12
Auris Medical Extends its Drug Discovery Agreement with King's College 12
Auris Medical Enters Into Agreement With Medidata Solutions 13
Equity Offering 13
Auris Medical Raises USD10 Million in Public Offering of Units 13
Auris Medical to Raise up to USD35 Million in Public Offering of Shares 15
Auris Medical Raises USD25 Million in Public Offering of Shares 16
Auris Medical Completes Underwriters Partial Exercise of Over-Allotment Option of IPO for USD60.7 Million 17
Auris Medical Holding AG - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Auris Medical Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Auris Medical Holding AG, Deals By Therapy Area, 2011 to YTD 2017 8
Auris Medical Holding AG, Medical Devices Deals, 2011 to YTD 2017 9
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Auris Medical Raises US$51 Million In Series C Financing 11
Auris Medical Extends its Drug Discovery Agreement with King's College 12
Auris Medical Enters Into Agreement With Medidata Solutions 13
Auris Medical Raises USD10 Million in Public Offering of Units 13
Auris Medical to Raise up to USD35 Million in Public Offering of Shares 15
Auris Medical Raises USD25 Million in Public Offering of Shares 16
Auris Medical Completes Underwriters Partial Exercise of Over-Allotment Option of IPO for USD60.7 Million 17
Auris Medical Holding AG, Key Competitors 19
Auris Medical Holding AG, Key Employees 20
Auris Medical Holding AG, Subsidiaries 21

List of Figures
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Auris Medical Holding AG, Medical Devices Deals, 2011 to YTD 2017 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838